Stockholm Stock Exchange | Large Cap
Sobi
+1.18%
Latest
+13.13%
3 months
SEBNordea MarketsPareto SecuritiesCarnegieBerenbergDeutsche BankMorgan StanleyJefferiesRBCHSBCDNB MarketsKepler CheuvreuxRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalBarclaysHandelsbankenSEB EquitiesABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia